California Cancer Reporting System Standards Volume I: Abstracting and Coding Procedures
Site |
Histology |
C50.0-C50.6, C50.8-C50.9 |
8000-9136, 9141-9582, 9700-9701 |
Factor |
CCR/SEER |
CoC |
CER |
Description |
SSF 1 |
X |
X |
X |
Estrogen Receptor (ER) Assay |
SSF 2 |
X |
X |
X |
Progesterone Receptor (PR) Assay |
SSF 3 |
X |
X |
X |
Number of Positive Ipsilateral Level I-II Axillary Lymph Nodes |
SSF 4 |
X |
X |
X |
Immunohistochemistry (IHC) of Regional Lymph Nodes |
SSF 5 |
X |
X |
X |
Molecular (MOL) Studies of Regional Lymph Nodes |
SSF 6 |
X |
X |
X |
Size of Tumor--Invasive Component |
SSF 7 |
X |
X |
X |
Nottingham or Bloom-Richardson (BR) Score/Grade |
SSF 8 |
X |
X |
X |
HER2: Immunohistochemistry (IHC) Lab Value |
SSF 9 |
X |
X |
X |
HER2: Immunohistochemistry (IHC) Test Interpretation |
SSF 10 |
X |
X |
X |
HER2: Fluorescence In Situ Hybridization (FISH) Lab Value |
SSF 11 |
X |
X |
X |
HER2: Fluorescence In Situ Hybridization (FISH) Test Interpretation |
SSF 12 |
X |
X |
X |
HER2: Chromogenic In Situ Hybridization (CISH) Lab Value |
SSF 13 |
X |
X |
X |
HER2: Chromogenic In Situ Hybridization (CISH) Test Interpretation |
SSF 14 |
X |
X |
X |
HER2: Result of other or unknown test |
SSF 15 |
X |
X |
X |
HER2: Summary Result of Testing |
SSF 16 |
|
|
X |
Combinations of ER, PR, and HER2 Results |
SSF 17 |
|
|
|
|
SSF 18 |
|
|
|
|
SSF 19 |
|
|
|
|
SSF 20 |
|
|
|
|
SSF 21 |
X |
X |
X |
Response to Neoadjuvant Therapy |
SSF 22 |
X |
X |
X |
Multigene Signature Method |
SSF 23 |
X |
X |
X |
Multigene Signature Results |
SSF 24 |
|
|
|
|
SSF 25 |
|
|
|
|
Site |
Histology |
C18.0, C18.2-C18.9 |
8000-8152, 8154-8231, 8243-8245, 8247-8248, 8250-8934, 8940-9136, 9141-9582, 9700-9701 |
Factor |
CCR/SEER |
CoC |
CER |
Description |
SSF 1 |
X |
X |
X |
Carcinoembryonic Antigen (CEA) |
SSF 2 |
X |
X |
X |
Clinical Assessment of Regional Lymph Nodes |
SSF 3 |
X |
X |
X |
Carcinoembryonic Antigen (CEA) Lab Value |
SSF 4 |
X |
X |
X |
Tumor Deposits |
SSF 5 |
|
|
|
|
SSF 6 |
X |
X |
X |
Circumferential Resection Margin (CRM) |
SSF 7 |
|
|
X |
Microsatellite Instability (MSI) |
SSF 8 |
X |
X |
X |
Perineural Invasion |
SSF 9 |
X |
X |
X |
KRAS |
SSF 10 |
|
|
X |
18q Loss of Heterozygosity (LOH) |
SSF 11 |
|
|
|
|
SSF 12 |
|
|
|
|
SSF 13 |
|
|
|
|
SSF 14 |
|
|
|
|
SSF 15 |
|
|
|
|
SSF 16 |
|
|
|
|
SSF 17 |
|
|
|
|
SSF 18 |
|
|
|
|
SSF 19 |
|
|
|
|
SSF 20 |
|
|
|
|
SSF 21 |
|
|
|
|
SSF 22 |
|
|
|
|
SSF 23 |
|
|
|
|
SSF 24 |
|
|
|
|
SSF 25 |
|
|
|
|
Site |
Histology |
C18.0, C18.2-C18.9 |
8153, 8240-8242, 8246, 8249 |
Factor |
CCR/SEER |
CoC |
CER |
Description |
SSF 1 |
|
|
|
OBSOLETE - Carcinoembryonic Antigen (CEA) |
SSF 2 |
X |
X |
X |
Clinical Assessment of Regional Lymph Nodes |
SSF 3 |
|
|
|
|
SSF 4 |
|
|
|
|
SSF 5 |
|
|
|
|
SSF 6 |
|
|
|
|
SSF 7 |
|
|
|
|
SSF 8 |
|
|
|
|
SSF 9 |
|
|
|
|
SSF 10 |
|
|
|
|
SSF 11 |
|
|
|
|
SSF 12 |
|
|
|
|
SSF 13 |
|
|
|
|
SSF 14 |
|
|
|
|
SSF 15 |
|
|
|
|
SSF 16 |
X |
X |
X |
Serum Chromogranin A (CgA) Lab Value |
SSF 17 |
X |
X |
X |
Urinary 5-Hydroxyindoleacetic Acid (5-HIAA) Lab Value |
SSF 18 |
|
|
|
|
SSF 19 |
|
|
|
|
SSF 20 |
|
|
|
|
SSF 21 |
|
|
|
|
SSF 22 |
|
|
|
|
SSF 23 |
|
|
|
|
SSF 24 |
|
|
|
|
SSF 25 |
|
|
|
|
Site |
Histology |
C18.0, C18.2-C18.9 |
8935-8936 |
Factor |
CCR/SEER |
CoC |
CER |
Description |
SSF 1 |
|
|
|
OBSOLETE FOR 2010 (Pre-Operative Carcinoembryonic Antigen (CEA)) |
SSF 2 |
|
|
|
OBSOLETE FOR 2010 (Clinical Assessment of Regional Lymph Nodes) |
SSF 3 |
|
|
|
|
SSF 4 |
|
|
|
|
SSF 5 |
|
|
|
|
SSF 6 |
|
|
|
|
SSF 7 |
|
|
|
|
SSF 8 |
|
|
|
|
SSF 9 |
|
|
|
|
SSF 10 |
|
|
|
|
SSF 11 |
X |
X |
X |
Mitotic Count |
SSF 12 |
X |
X |
X |
KIT Gene Immunohistochemistry (IHC) |
SSF 13 |
|
|
|
|
SSF 14 |
|
|
|
|
SSF 15 |
|
|
|
|
SSF 16 |
|
|
|
|
SSF 17 |
|
|
|
|
SSF 18 |
|
|
|
|
SSF 19 |
|
|
|
|
SSF 20 |
|
|
|
|
SSF 21 |
|
|
|
|
SSF 22 |
|
|
|
|
SSF 23 |
|
|
|
|
SSF 24 |
|
|
|
|
SSF 25 |
|
|
|
|
Site |
Histology |
C19.9, C20.9 |
8000-8152, 8154-8231, 8243-8245, 8247, 8248, 8250-8934, 8940-9136, 9141-9582, 9700-9701 |
Factor |
CCR/SEER |
CoC |
CER |
Description |
SSF 1 |
X |
X |
X |
Carcinoembryonic Antigen (CEA) |
SSF 2 |
X |
X |
X |
Clinical Assessment of Regional Lymph Nodes |
SSF 3 |
X |
X |
X |
Carcinoembryonic Antigen (CEA) Lab Value |
SSF 4 |
X |
X |
X |
Tumor Deposits |
SSF 5 |
|
|
X |
Tumor Regression Grade |
SSF 6 |
X |
X |
X |
Circumferential Resection Margin (CRM) |
SSF 7 |
|
|
X |
Microsatellite Instability (MSI) |
SSF 8 |
X |
X |
X |
Perineural Invasion |
SSF 9 |
X |
X |
X |
KRAS |
SSF 10 |
|
|
X |
18q Loss of Heterozygosity (LOH) |
SSF 11 |
|
|
|
|
SSF 12 |
|
|
|
|
SSF 13 |
|
|
|
|
SSF 14 |
|
|
|
|
SSF 15 |
|
|
|
|
SSF 16 |
|
|
|
|
SSF 17 |
|
|
|
|
SSF 18 |
|
|
|
|
SSF 19 |
|
|
|
|
SSF 20 |
|
|
|
|
SSF 21 |
|
|
|
|
SSF 22 |
|
|
|
|
SSF 23 |
|
|
|
|
SSF 24 |
|
|
|
|
SSF 25 |
|
|
|
|
Site |
Histology |
C19.9, C20.9 |
8153, 8240-8242, 8246, 8249 |
Factor |
CCR/SEER |
CoC |
CER |
Description |
SSF 1 |
|
|
|
OBSOLETE - Carcinoembryonic Antigen (CEA) |
SSF 2 |
X |
X |
X |
Clinical Assessment of Regional Lymph Nodes |
SSF 3 |
||||
SSF 4 |
||||
SSF 5 |
||||
SSF 6 |
||||
SSF 7 |
||||
SSF 8 |
||||
SSF 9 |
||||
SSF 10 |
||||
SSF 11 |
||||
SSF 12 |
||||
SSF 13 |
||||
SSF 14 |
||||
SSF 15 |
||||
SSF 16 |
X |
X |
X |
Serum Chromogranin A (CgA) Lab Value |
SSF 17 |
X |
X |
X |
Urinary 5-Hydroxyindoleacetic Acid (5-HIAA) Lab Value |
SSF 18 |
|
|
|
|
SSF 19 |
|
|
|
|
SSF 20 |
|
|
|
|
SSF 21 |
|
|
|
|
SSF 22 |
|
|
|
|
SSF 23 |
|
|
|
|
SSF 24 |
|
|
|
|
SSF 25 |
|
|
|
|
Site |
Histology |
C19.9, C20.9 |
8935-8936 |
Factor |
CCR/SEER |
CoC |
CER |
Description |
SSF 1 |
|
|
|
OBSOLETE FOR 2010 (Pre-Operative Carcinoembryonic Antigen (CEA)) |
SSF 2 |
|
|
|
OBSOLETE FOR 2010 (Clinical Assessment of Regional Lymph Nodes) |
SSF 3 |
|
|
|
|
SSF 4 |
|
|
|
|
SSF 5 |
|
|
|
|
SSF 6 |
|
|
|
|
SSF 7 |
|
|
|
|
SSF 8 |
|
|
|
|
SSF 9 |
|
|
|
|
SSF 10 |
|
|
|
|
SSF 11 |
X |
X |
X |
Mitotic Count |
SSF 12 |
X |
X |
X |
KIT Gene Immunohistochemistry (IHC) |
SSF 13 |
|
|
|
|
SSF 14 |
|
|
|
|
SSF 15 |
|
|
|
|
SSF 16 |
|
|
|
|
SSF 17 |
|
|
|
|
SSF 18 |
|
|
|
|
SSF 19 |
|
|
|
|
SSF 20 |
|
|
|
|
SSF 21 |
|
|
|
|
SSF 22 |
|
|
|
|
SSF 23 |
|
|
|
|
SSF 24 |
|
|
|
|
SSF 25 |
|
|
|
|
Site |
Histology |
C18.1 |
8000-8152, 8154-8231, 8243-8245, 8247-8248, 8250-8934, 8940-9136, 9141-9582, 9700-9701 |
Factor |
CCR/SEER |
CoC |
CER |
Description |
SSF 1 |
X |
X |
X |
Carcinoembryonic Antigen (CEA) |
SSF 2 |
X |
X |
X |
Clinical Assessment of Regional Lymph Nodes |
SSF 3 |
X |
X |
X |
Carcinoembryonic Antigen (CEA) Lab Value |
SSF 4 |
|
|
|
|
SSF 5 |
|
|
|
|
SSF 6 |
|
|
|
|
SSF 7 |
|
|
X |
Microsatellite Instability (MSI) |
SSF 8 |
|
|
|
|
SSF 9 |
|
|
|
|
SSF 10 |
|
|
X |
18q Loss of Heterozygosity (LOH) |
SSF 11 |
X |
X |
X |
Histopathological Grading |
SSF 12 |
|
|
|
|
SSF 13 |
|
|
|
|
SSF 14 |
|
|
|
|
SSF 15 |
|
|
|
|
SSF 16 |
|
|
|
|
SSF 17 |
|
|
|
|
SSF 18 |
|
|
|
|
SSF 19 |
|
|
|
|
SSF 20 |
|
|
|
|
SSF 21 |
|
|
|
|
SSF 22 |
|
|
|
|
SSF 23 |
|
|
|
|
SSF 24 |
|
|
|
|
SSF 25 |
|
|
|
|
Site |
Histology |
C18.1 |
8153, 8240-8242, 8246, 8249 |
Factor |
CCR/SEER |
CoC |
CER |
Description |
SSF 1 |
|
|
|
OBSOLETE FOR 2010 (Pre-Operative Carcinoembryonic Antigen (CEA)) |
SSF 2 |
X |
X |
X |
Clinical Assessment of Regional Lymph Nodes |
SSF 3 |
|
|
|
|
SSF 4 |
|
|
|
|
SSF 5 |
|
|
|
|
SSF 6 |
|
|
|
|
SSF 7 |
|
|
|
|
SSF 8 |
|
|
|
|
SSF 9 |
|
|
|
|
SSF 10 |
|
|
|
|
SSF 11 |
|
|
|
|
SSF 12 |
|
|
|
|
SSF 13 |
|
|
|
|
SSF 14 |
|
|
|
|
SSF 15 |
|
|
|
|
SSF 16 |
|
|
|
|
SSF 17 |
|
|
|
|
SSF 18 |
|
|
|
|
SSF 19 |
|
|
|
|
SSF 20 |
|
|
|
|
SSF 21 |
|
|
|
|
SSF 22 |
|
|
|
|
SSF 23 |
|
|
|
|
SSF 24 |
|
|
|
|
SSF 25 |
|
|
|
|
Site |
Histology |
C18.1 |
8935-8936 |
Factor |
CCR/SEER |
CoC |
CER |
Description |
SSF 1 |
|
|
|
OBSOLETE FOR 2010 (Pre-Operative Carcinoembryonic Antigen (CEA)) |
SSF 2 |
|
|
|
OBSOLETE FOR 2010 (Clinical Assessment of Regional Lymph Nodes) |
SSF 3 |
|
|
|
|
SSF 4 |
|
|
|
|
SSF 5 |
|
|
|
|
SSF 6 |
|
|
|
|
SSF 7 |
|
|
|
|
SSF 8 |
|
|
|
|
SSF 9 |
|
|
|
|
SSF 10 |
|
|
|
|
SSF 11 |
X |
X |
X |
Mitotic Count |
SSF 12 |
X |
X |
X |
KIT Gene Immunohistochemistry (IHC) |
SSF 13 |
|
|
|
|
SSF 14 |
|
|
|
|
SSF 15 |
|
|
|
|
SSF 16 |
|
|
|
|
SSF 17 |
|
|
|
|
SSF 18 |
|
|
|
|
SSF 19 |
|
|
|
|
SSF 20 |
|
|
|
|
SSF 21 |
|
|
|
|
SSF 22 |
|
|
|
|
SSF 23 |
|
|
|
|
SSF 24 |
|
|
|
|
SSF 25 |
|
|
|
|
Site |
Histology |
C42.1 |
9863, 9875, 9876, 9945, 9946 |
Factor |
CCR/SEER |
CoC |
CER |
Description |
SSF 1 |
X |
X |
X |
JAK-2 (also known as Janus Kinase 2 and JAK 2 Exon 12) |
SSF 2 |
|
|
|
|
SSF 3 |
|
|
|
|
SSF 4 |
|
|
|
|
SSF 5 |
|
|
|
|
SSF 6 |
|
|
|
|
SSF 7 |
|
|
|
|
SSF 8 |
|
|
|
|
SSF 9 |
|
|
|
|
SSF 10 |
|
|
|
|
SSF 11 |
||||
SSF 12 |
||||
SSF 13 |
|
|
|
|
SSF 14 |
|
|
|
|
SSF 15 |
|
|
|
|
SSF 16 |
|
|
|
|
SSF 17 |
|
|
|
|
SSF 18 |
|
|
|
|
SSF 19 |
|
|
|
|
SSF 20 |
|
|
|
|
SSF 21 |
|
|
|
|
SSF 22 |
|
|
|
|
SSF 23 |
|
|
|
|
SSF 24 |
|
|
|
|
SSF 25 |
|
|
|
|